Research

Hormonal

Off-label prescribing of semaglutide (Ozempic) for weight loss causes significant supply shortages for patients with type 2 diabetes who require the medication for its FDA-approved indication.

If you are considering Ozempic for weight loss, understand that it is a serious medication, not a cosmetic shortcut. It works by mimicking hormones that regulate hunger, but stopping it often leads to significant weight regain. Be aware that high demand for off-label use has caused shortages for people who need it for diabetes, so discuss ethical access and long-term sustainability with your doctor before starting.

ModerateSupportsMEDIUM confidence
However, the off-label prescribing of Ozempic may interfere with the availability of Ozempic for individuals with diabetes. As of this article, the hashtag #ozempic on Tik Tok has 931.8 million views and it is rapidly becoming associated as a “vanity” medication rather than a critical treatment for individuals with diabetes.
Magda Wojtara et al. · Qeios · 2023

Why this rating

The paper is a narrative review/analysis of prescribing trends and policy, not a primary clinical trial, relying on secondary sources for claims about shortages.

Source

Examining Off-Label Prescribing of Ozempic for Weight-Loss

Magda Wojtara et al. · Qeios · 2023

DOI 10.32388/t6y97s

narrative_reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →